The stock finished 14.56% below its 52-week high of $329.16 reached on 3 March, while trading volume of 2.3 million was slightly below its 50-day average.
Record profits, yet a falling stock. Is CME a stable giant or a legacy player losing the tech race to nimbler rivals?
As rivals push 24/7 trading, can CME's new crypto products prevent it from being outmaneuvered in the digital asset space?